Wunderman Thompson launches push to communicate with late-stage breast cancer patients
The effort takes into account differences between these patients and oft-targeted early-stage ones.
News
Six degrees of medical marketing separation: Web of connections among four marketers
Do we have our first direct connection between an MM+M-world luminary and Kevin Bacon himself? Indeed we do.
Five things for pharma marketers to know: Thursday, October 22, 2020
Purdue Pharma pleads guilty; CDC: 300,000 more people died in the U.S. from January-October than recent years; Arthritis drug shows inconsistent results in treating COVID-19.
Coronavirus Briefing: Chasing the wave, celebrity COVID campaigns, masks and mass transportation
This week’s Haymarket Media Coronavirus Briefing is 1,135 words and will take you six minutes to read.
Philippe Krakowsky to succeed Michael Roth as IPG CEO
Krakowsky will take the helm effective Jan. 1; Roth to move into executive chairman role.
Five things for pharma marketers to know: Wednesday, October 21, 2020
CA, NY to review any federally approved COVID-19 vaccine; AstraZeneca coronavirus vaccine trial expected to resume soon; Lyra Health partners with meditation app Calm.
Golin loses appeal of $6m California anti-tobacco RFP
The state’s Department of Health confirmed Rally’s win of the account.
Zimmer Biomet attempts to ease concerns about joint surgery during the pandemic
“Don’t Let Pain Gain on You” targets patients and caregivers alike.
Five things for pharma marketers to know: Tuesday, October 20, 2020
Only 58% of Americans say they are likely to get a COVID-19 vaccine; CDC mandate strongly recommends mask wearing when traveling; UNICEF is buying and distributing more than half a billion single-dose syringes to prep for eventual COVID-19 vaccine.
Figs pulls ad. How should the scrubs brand handle future marketing efforts?
The brand’s latest ad offended female healthcare pros.
Want to read more?
Please login or register first to view this content.
